Soffer DE, Marston NA, Maki KC, et al
Integrating These Advances Into Clinical Practice Endocrinologists already evaluate patient eligibility based on BMI, comorbidity, and previous medication response
Our formulation includes B12 to reduce nausea during dose escalation and glycine to support muscle preservation during weight loss
In this review, we discuss the pipeline of obesity pharmacotherapies with focus on entero-pancreatic hormone-based molecules, and we evaluate the data from early and late phase clinical trials on their safety and efficacy on WL in people with and without T2D
Before starting or restarting one of these medications, I encourage you to look beyond the promise of weight loss and consider the full picture: your mental health, your relationship with food, your energy levels, and your values
Out of the three brand-name versions of semaglutide, Wegovy is the only one whose prescribing information (PI) lists hair loss as a potential adverse reaction